ExPEC9V
Vaccineexperimental
Clinical trial activity
1 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 24, 2023 (NCT06134804)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06134804 | Phase 3 | Oct 24, 2023 | — |
Showing 1 of 1 trials
Page 1 / 1